Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
[195 Pages Report] Expanding at a CAGR of 4.9%, the global compression garments and stockings market is expected to increase from a valuation of US$ 2.8 Billion in 2022 to US$ 3.9 Billion by 2029.
Data Points | market insights |
---|---|
market Value 2021 | USD 2.6 Billion |
market Value 2022 | USD 2.8 Billion |
market Value 2029 | USD 3.9 Billion |
CAGR 2022 to 2029 | 4.9% |
Share of Top 5 Countries | 52.1% |
Key Players | The key players in the Compression Garments and Stockings market are SIGVARIS, medi GmBH & Co KG, 3M, BSN Medical, Covidien Ltd., Therafirm, 2XU Pty. Ltd., Santemol Group Medikal, Leonisa, Inc., and Nouvelle, Inc. Medical Z. |
The global compression garments and stockings market contributed more than 3.1% of the market share to the medical clothing market, which accounted for around USD 86.0 billion in 2021.
Compression garments are a type of garment that is tight-fitting and elastic in nature. It exerts graduated pressure over certain areas of the body that ensures continuous blood flow throughout the veins. These garments can reduce peripheral swelling and are designed to restore as well as promote normal fluid circulation within the body.
Compression stockings use stronger elastics than normal day dresses or athletic stockings and socks to create significant pressure on the target area and provide relief from light-headedness or dizziness. The demand for these products is rising because compression therapy helps in decreasing venous pressure, avoids venous stasis and injuries of venous walls, and helps with heavy pain in the legs.
The rising awareness through mutual efforts by the social body and government body is also helping the market to grow drastically during the forecast period from 2022 to 2029. An increase in awareness among the masses is leading to the development and adoption of compression-absorbing garments in developing nations such as India and China.
For instance, in January 2021, the AIC-NIFT TEA Incubation Centre for Textiles and Apparels announced that they are going to support entrepreneurs making compression garments and socks using sustainable materials.
As a result, there is an increasing demand for compression garments and stockings seen during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 4.81% |
H1, 2022 Projected | 4.86% |
H1, 2022 Outlook | 4.76% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 5 ↓ |
The market for compression garments and stockings is expected to decline by 05 basis share points (BPS) in H1-2022 (O) when compared to H1-2021, according to an FMI assessment.
Variations in patient compliance, stage of disease, and low adoption rates owing to the high-cost burden, can be attributed to the lowering BPS value for the compression garments and stockings market. Furthermore, the variation between the H1-2022 outlook and H1-2022 projected period reflected a decline in BPS change by 10 BPS.
The global compression garments and stockings market is influenced by product compliance testing and market approvals. Macroeconomic, regulatory, and industrial variables, all have an impact on the market. Differential pressure elements on various medical compression stockings for different disease indications are a key market development factor.
Other market segments, on the other hand, are expected to perform objectively and profitably in the second half of the projection period, particularly due to pressure distribution, safety, effectiveness, and retention of compression garments, which have considerable health benefits.
Furthermore, with the advancement of graduated pressure treatment, the market for compression garments and stockings is expected to witness a positive outlook.
The sale of compression garments and stockings grew at a CAGR of 4.5% between 2015 and 2021. The valuation of the industry is increasing with an increase in certain disorders that require compression garments to manage their disease conditions.
For instance, according to SAGE Journal’s publication, there were approximately 122,000, 263,000, 345,000, 253,000, 85,000, 230,000, and 643,000 new or recurrent deep venous disease-related venous leg ulcers (DRV) in Australia, France, Germany, Italy, Spain, UK, and the USA respectively in the year 2019.
These leg ulcers have mainly a venous origin and are caused by high pressure in the veins. This can further lead to blockage and weakness of the valves in the veins of the leg. To prevent and treat venous ulcers, one has to reduce the pressure using external appliances such as compression garments, which absorb the shock, or pressure on the legs.
In addition, increasing cases of obesity are also playing a key role in driving the market of compression garments and stockings. Obesity has various associated issues such as swelling of the foot due to poor circulation. Obesity has been noted by the WHO to be common in the pediatric population as well.
For instance, according to WHO, there were approximately 39 million overweight or obese children under the age of 5 in 2020. Thus, to manage the swelling of the foot due to poor circulation, this population uses compression garments and stockings that benefit the industry by increasing the volume of products manufactured and distributed.
In conjunction, increasing case of varicose veins due to the aging population is a common issue. Aging leads to wear and tear on the valves in the veins. This tear leads to the backflow of some blood into the veins and results in causing varicose veins.
Lifestyle alterations like a decrease in physical activity can lead to varicose veins due to less-than-ideal blood flood to the site. An increase in weight during pregnancy can lead to increased pressure on the walls of the veins, which can also further lead to varicose vein complications.
Considering all these factors, FMI expects global compression garments and stockings to grow at a CAGR of 4.9% through 2029.
The popularity of functional sportswear and sporting goods is increasing due to the advances made in the fiber and polymer sciences and related production techniques.
The market is likely to increase with new developments in fabric and garment technologies. The use of nanotechnology, microfibers, and insulators in sportswear and compression garments and stockings are a few new technologies that can increase the demand for the product in the market. This creates more opportunities for manufacturers in the compression sportswear and athletic category to utilize these technologies in their products and attract more people for using them.
All of these reasons are creating enormous opportunities in the market for compression garments and stockings in the approaching years.
The demand for compression garments and stockings can be harmed due to the availability of alternative therapies in the market. For example, compression therapy supports inhibiting reflux, reducing the release of inflammatory cytokines, and decreasing fluid leakage from capillaries. Thus, this therapy is helpful in preventing secondary complications and assists by slowing the disease progression.
Alternate treatments for chronic venous insufficiency such as local wound care, dressings, topical or systemic antibiotics, other pharmacologic agents, surgery, and adjunctive therapy are also going to harm the compression garments and stockings sale during the forecast period.
The coronavirus continuously spread over the world, resulting in confusion and disturbances in every aspect of an individual’s life, from how they socialize to how they seek medical treatment. COVID-19 is a global public health emergency that has affected almost every medical and non-medical industry in the world.
This virus has harmed the industry of compression garments and stockings as well. The pandemic and lockdown resulted in the postponement and cancellation of various national and international sports in the world. Cancellation in various tournaments leads to a reduction in the demand for compression garments and stockings which athletes prefer to wear during sports to reduce swelling and pain.
Lockdowns in USA, England, and APAC nations such as China and India have caused medical device manufacture and shipping to be delayed. Thus, making the situation more difficult for manufacturers and distributors.
However, with a decrease in positive COVID-19 cases, the diagnostic equipment market is regaining its original position and maintaining the development and distribution of devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In 2021, the United States accounted for about 80.3% of the North American compression garments and stockings market. The high market share is primarily due to the increasing prevalence of obesity in the people of the region.
According to CDC, 42.4% was the prevalence of obesity from 2017 to 2018 period in the USA As the obesity rate increases, the sale of products like compression garments and stockings that helps in the prevention of its associated problems also increases.
Germany accounted for around 19.8% of the Western Europe compression garments and stockings market share in 2021. Germany is a very active country in terms of sports and games. Various international-level sports are played there which leads to an increasing rate of people affected by sports injuries.
According to Springer Nature Switzerland AG, during the UEFA Regions Cup 2019 for football that took place in Germany, overall injury incidence was 12.5 per 1000 h total football exposure and 43.5 per 1000 h for match exposure.
Japan accounted for around 2.4% of the global market share in 2021. Factors such as the increasing number of people belonging to the older population that are more sensitive to any kind of injury and fracture because of the weaker body are responsible for risen use of compression garments and stockings. For instance, according to World Bank data, there were 28% of people in Japan belonged to the aged of above 65 years in 2020.
India accounted for 24.7% market share of the APEJ region in 2021 and is expected to show a similar trend in the coming years also. The rise in the number of registered surgeons in the country is benefiting the market by increasing the advancement and development in the orthopedic department. For instance, according to Springer's publication, there were 712 registered surgeons in IJR (Indian Joint Registry) database until June 2020.
By product, compression garments accounted for the largest share of 92.6% in 2021, expanding at 5.1% CAGR during the forecast period. Compression garments have a larger share because they have multiple applications in the medical field to prevent and treat burns, low blood pressure, muscle strains, and sprains.
It has other applications too such as antimicrobial protection, antistatic properties, breathability, enhanced fabric durability, and stain-release technology.
By application, Varicose Veins hold over 47.0% of the market in 2021. This is because the chronic venous disease is a very common condition in developed nations of Europe and the USA Increasing cases of varicose veins due to an aging population is a common problem.
By distribution channel, hospitals hold around 34.6% of the market in 2021 and are expected to dominate in the future also due to a large number of people suffering from arthritis and sports injuries admitted to hospital for diagnosis and to get treatment for the diseases.
Major competitors in the compression garments and stockings market are concentrating their efforts on expanding their worldwide and regional footprints through strategic acquisitions and mergers, as well as operational growth.
Companies in the compression garments and stockings market are following new product innovations and launches, regulatory approvals, and acquisition as key strategies.
Key players are focusing on the development of advanced and cost-effective products establishing distribution agreements to increase geographic reach, especially in the Asia Pacific region. Moreover, companies are targeting Asia regions by establishing manufacturing units in order to reduce manufacturing costs. For instance:
Attribute | Details |
---|---|
Forecast Period | 2022 to 2029 |
Historical Data Available for | 2015 to 2021 |
market Analysis | USD Million for Value |
Key Regions Covered | North America, Western Europe, Eastern Europe, APEJ, Japan, Latin America, and the Middle East & Africa (MEA) |
Key Countries Covered | The USA, China, Canada, Japan, India, Spain, Italy, ANZ, France, Brazil, Germany, Russia, South Korea, Association of Southeast Asian Nations, The UK, Mexico, Poland, GCC, South Africa, Benelux, and Nordic |
Key Segments Covered | Product, Application, Distribution Channel, and Region |
Key Companies Profiled |
|
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
By Product :
By Application :
By Distribution Channel :
By Region :
The global compression garments and stockings market is worth US$ 2.6 Billion in 2021 and is set to expand 1.4X over the forecast period.
The compression garments and stockings market is expected to reach US$ 3.9 Billion by the end of 2029, with sales revenue expected to grow at a 4.9% CAGR.
From 2015 to 2021, the market for compression garments and stockings market expanded at the rate of 4.5% CAGR.
Western Europe holds a 37.1% share in the global market of compression garments and stockings in 2021.
The compression garments and stockings market share of India was 24.7% in South Asia in the year 2021.
The demand for compression garments and stockings is expected to register a growth rate of 4.9% during the forecast period in the Western Europe market.
The demand for compression garments and stockings is expected to register a growth rate of around 6.4% CAGR during the forecast period in the APEJ market.
The compression garments and stockings market share of China was 37.8% in APEJ in the year 2021.
The USA, Germany, Canada, France, and the UK are the top 5 countries that are driving the demand for compression garments and stockings.
Leading companies of the compression garments and stockings market are SIGVARIS, medi GmBH & Co KG, 3M, BSN Medical, Covidien Ltd., Therafirm, 2XU Pty. Ltd., Santemol Group Medikal, Leonisa, Inc., Nouvelle, Inc. and Medical Z.
1. Executive Summary | Compression Garments and Stockings Market 2. Market Introduction 2.1. Global Market-Taxonomy 2.2. Definitions 3. Market Analysis 3.1. Global Market - Market Value Forecast 3.1.1. Market Size and Y-o-Y Growth 3.2. Absolute $ Opportunity 3.2.1. Global Market, Compression Garments Price Analysis Region, 2021 4. Market Dynamics 4.1. Drivers 4.2. Restraints 4.3. Opportunity 4.4. Trends 5. Global Market Analysis, By Product 5.1. Introduction 5.2. Basis Point Share (BPS) Analysis Product 5.3. Y-o-Y Growth Projections By Product 5.4. Global Compression Garments Absolute $ Opportunity By Product, 2022 to 2029 5.4.1. Compression Garments 5.4.2. Compression Stockings 5.5. Market Value (US$ Million) & Volume (Units) Analysis and Forecast Product, 2022 to 2029 Opportunity Analysis 5.6. Market Attractiveness By Product 6. Global Market Analysis, By Application 6.1. Introduction 6.2. Basis Point Share (BPS) Analysis Application 6.3. Y-o-Y Growth Projections By Application 6.4. Global Compression Garments Absolute $ Opportunity By Application, 2022 to 2029 6.4.1. Varicose Veins 6.4.2. Wound Care 6.4.3. Burn Cases 6.4.4. Oncology 6.4.5. Other Indications 6.5. Market Value (US$ Million) & Volume (Units) Analysis and Forecast Application, 2022 to 2029 Opportunity Analysis 6.6. Market Attractiveness By Application 7. Global Market Analysis, By Distribution Channel 7.1. Introduction 7.2. Basis Point Share (BPS) Analysis Distribution Channel 7.3. Y-o-Y Growth Projections By Distribution Channel 7.4. Global Compression Garments Absolute $ Opportunity By Distribution Channel, 2022 to 2029 7.4.1. Hospitals 7.4.2. Ambulatory Surgical Centres 7.4.3. Clinics 7.4.4. Online Sales 7.4.5. Other Healthcare Facilities 7.5. Market Value (US$ Million) & Volume (Units) Analysis and Forecast Distribution Channel, 2022 to 2029 Opportunity Analysis 7.6. Market Attractiveness By Distribution Channel 8. Global Market Analysis, By Region 8.1. Introduction 8.2. Basis Point Share (BPS) Analysis Region 8.3. Y-o-Y Growth Projections By Region 8.4. Global Compression Garments Absolute $ Opportunity By Region, 2022 to 2029 8.4.1. North America 8.4.2. Western Europe 8.4.3. Eastern Europe 8.4.4. Association of Southeast Asian Nations 8.4.5. Japan 8.4.6. Latin America 8.4.7. Middle East & Africa (MEA) 8.5. Market Value (US$ Million) & Volume (Units) Analysis and Forecast Region, 2022 to 2029 Opportunity Analysis 8.6. Market Attractiveness By Region 9. North America Market Analysis, 2022 to 2029 9.1. Introduction 9.2. Market Share Analysis Region 9.3. Y-o-Y Growth Projections By Region 9.4. North America Market Analysis and Forecast Country, 2022 to 2029 9.4.1. The USA 9.4.2. Canada 9.5. North America Market Value & Volume Analysis and Forecast, 2022 to 2029 9.5.1. Market Value & Volume Analysis and Forecast Country 9.5.2. Market Value & Volume Analysis and Forecast Product 9.5.3. Market Value & Volume Analysis and Forecast Application 9.5.4. Market Value & Volume Analysis and Forecast Distribution Channel 9.6. North America Market Attractiveness Analysis, 2022 to 2029 10. Western Europe Market Analysis, 2022 to 2029 10.1. Introduction 10.2. Market Share Analysis Country 10.3. Y-o-Y Growth Projections By Country 10.4. Western Europe Market Analysis and Forecast Country, 2022 to 2029 10.4.1. Germany 10.4.2. France 10.4.3. The UK 10.4.4. Italy 10.4.5. Spain 10.4.6. Rest of Western Europe 10.5. Western Europe Market Value & Volume Analysis and Forecast, 2022 to 2029 10.5.1. Market Value & Volume Analysis and Forecast Country 10.5.2. Market Value & Volume Analysis and Forecast Product 10.5.3. Market Value & Volume Analysis and Forecast Application 10.5.4. Market Value & Volume Analysis and Forecast Distribution Channel 10.6. Western Europe Market Attractiveness Analysis, 2022 to 2029 11. Eastern Europe Market Analysis, 2022 to 2029 11.1. Introduction 11.2. Market Share Analysis Country 11.3. Y-o-Y Growth Projections By Country 11.4. Eastern Europe Market Analysis and Forecast Country, 2022 to 2029 11.4.1. Russia 11.4.2. Poland 11.4.3. Rest of Eastern Europe 11.5. Eastern Europe Market Value & Volume Analysis and Forecast, 2022 to 2029 11.5.1. Market Value & Volume Analysis and Forecast Country 11.5.2. Market Value & Volume Analysis and Forecast Product 11.5.3. Market Value & Volume Analysis and Forecast Application 11.5.4. Market Value & Volume Analysis and Forecast Distribution Channel 11.6. Eastern Europe Market Attractiveness Analysis, 2022 to 2029 12. APEJ Market Analysis, 2022 to 2029 12.1. Introduction 12.2. Market Share Analysis Country 12.3. Y-o-Y Growth Projections By Country 12.4. APEJ Market Analysis and Forecast Country, 2022 to 2029 12.4.1. China 12.4.2. India 12.4.3. Australia and New Zealand 12.4.4. Association of Southeast Asian Nations 12.4.5. Rest of APEJ 12.5. APEJ Market Value & Volume Analysis and Forecast, 2022 to 2029 12.5.1. Market Value & Volume Analysis and Forecast Country 12.5.2. Market Value & Volume Analysis and Forecast Product 12.5.3. Market Value & Volume Analysis and Forecast Application 12.5.4. Market Value & Volume Analysis and Forecast Distribution Channel 12.6. APEJ Market Attractiveness Analysis, 2022 to 2029 13. Japan Market Analysis, 2022 to 2029 13.1. Introduction 13.2. Japan Market Value & Volume, Analysis, and Forecast, 2022 to 2029 13.2.1. Market Value & Volume Analysis and Forecast Country 13.2.2. Market Value & Volume Analysis and Forecast Product 13.2.3. Market Value & Volume Analysis and Forecast Application 13.2.4. Market Value & Volume Analysis and Forecast Distribution Channel 13.3. Japan Market Attractiveness Analysis, 2022 to 2029 14. Latin America Market Analysis, 2022 to 2029 14.1. Introduction 14.2. Market Share Analysis Country 14.3. Y-o-Y Growth Projections By Country 14.4. Latin America Market Analysis and Forecast Country, 2022 to 2029 14.4.1. Brazil 14.4.2. Mexico 14.4.3. Rest of Latin America 14.5. Latin America Market Value & Volume Analysis and Forecast, 2022 to 2029 14.5.1. Market Value & Volume Analysis and Forecast Country 14.5.2. Market Value & Volume Analysis and Forecast Product 14.5.3. Market Value & Volume Analysis and Forecast Application 14.5.4. Market Value Analysis and Forecast Distribution Channel 14.6. Latin America Market Attractiveness Analysis, 2022 to 2029 15. Middle East and Africa Market Analysis, 2022 to 2029 15.1. Introduction 15.2. Market Share Analysis Country 15.3. Y-o-Y Growth Projections By Country 15.4. MEA Market Analysis and Forecast Country, 2022 to 2029 15.4.1. GCC Countries 15.4.2. South Africa 15.4.3. Rest of MEA 15.5. MEA Market Value & Volume Analysis and Forecast, 2022 to 2029 15.5.1. Market Value & Volume Analysis and Forecast Country 15.5.2. Market Value & Volume Analysis and Forecast Product 15.5.3. Market Value & Volume Analysis and Forecast Application 15.5.4. Market Value & Volume Analysis and Forecast Distribution Channel 15.6. MEA Market Attractiveness Analysis, 2022 to 2029 16. Competition Landscape 16.1. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments) 16.1.1. 3M 16.1.2. BSN Medical 16.1.3. Covidien Ltd. (a Medtronic PLC. Company) 16.1.4. medi GmBH & Co KG 16.1.5. SIGVARIS 16.1.6. Therafirm 16.1.7. 2XU Pty. Ltd. 16.1.8. Santemol Group Medikal 16.1.9. Leonisa, Inc. 16.1.10. Nouvelle, Inc. 16.1.11. Medical Z 17. Research Methodology 18. Assumptions and Acronyms Used
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Market Value (US$ Million) Analysis and Forecast Products, 2015 to 2029 Table 02: Global Market Volume (Units) Analysis and Forecast Products, 2015 to 2029 Table 03: Global Market Value (US$ Million) Analysis and Forecast Applications, 2015 to 2029 Table 04: Global Market Volume (Units) Analysis and Forecast Applications, 2015 to 2029 Table 05: Global Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 06: Global Market Volume (Units) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 07: Global Market Value (US$ Million) Analysis and Forecast Region, 2015 to 2029 Table 08: Global Market Volume (Units) Analysis and Forecast Region, 2015 to 2029 Table 09: North America Market Value (US$ Million) Analysis and Forecast Country, 2015 to 2029 Table 10: North America Market Volume (Units) Analysis and Forecast Country, 2015 to 2029 Table 11: North America Market Value (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 12: North America Market Volume (Units) Analysis and Forecast Product, 2015 to 2029 Table 13: North America Market Value (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 14: North America Market Volume (Units) Analysis and Forecast Application, 2015 to 2029 Table 15: North America Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 16: North America Market Volume (Units) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 17: Western Europe Market Value (US$ Million) Analysis and Forecast Country, 2015 to 2029 Table 18: Western Europe Market Volume (Units) Analysis and Forecast Country, 2015 to 2029 Table 19: Western Europe Market Value (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 20: Western Europe Market Volume (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 21: Western Europe Market Value (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 22: Western Europe Market Volume (Units) Analysis and Forecast Application, 2015 to 2029 Table 23: Western Europe Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 24: Western Europe Market Volume (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 25: Eastern Europe Market Value (US$ Million) Analysis and Forecast Country, 2015 to 2029 Table 26: Eastern Europe Market Volume (Units) Analysis and Forecast Country, 2015 to 2029 Table 27: Eastern Europe Market Value (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 28: Eastern Europe Market Volume (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 29: Eastern Europe Market Value (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 30: Eastern Europe Market Volume (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 31: Eastern Europe Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 32: Eastern Europe Market Volume (Units) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 33: APEJ Market Value (US$ Million) Analysis and Forecast Country, 2015 to 2029 Table 34: APEJ Market Volume (Units) Analysis and Forecast Country, 2015 to 2029 Table 35: APEJ Market Value (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 36: APEJ Market Volume (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 37: APEJ Market Value (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 38: APEJ Market Volume (Units) Analysis and Forecast Application, 2015 to 2029 Table 39: APEJ Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 40: APEJ Market Volume (Units) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 41: Japan Market Value (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 42: Japan Market Volume (Units) Analysis and Forecast Product, 2015 to 2029 Table 43: Japan Market Value (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 44: Japan Market Volume (Units) Analysis and Forecast Application, 2015 to 2029 Table 45: Japan Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 46: Japan Market Volume (Units) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 47: Latin America Market Value (US$ Million) Analysis and Forecast Country, 2015 to 2029 Table 48: Latin America Market Volume (Units) Analysis and Forecast Country, 2015 to 2029 Table 49: Latin America Market Value (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 50: Latin America Market Volume (Units) Analysis and Forecast Product, 2015 to 2029 Table 51: Latin America Market Value (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 52: Latin America Market Volume (Units) Analysis and Forecast Application, 2015 to 2029 Table 53: Latin America Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 54: Latin America Market Volume (Units) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 55: MEA Market Value (US$ Million) Analysis and Forecast Country, 2015 to 2029 Table 56: MEA Market Volume (Units) Analysis and Forecast Country, 2015 to 2029 Table 57: MEA Market Value (US$ Million) Analysis and Forecast Product, 2015 to 2029 Table 58: MEA Market Volume (Units) Analysis and Forecast Product, 2015 to 2029 Table 59: MEA Market Value (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 60: MEA Market Volume (US$ Million) Analysis and Forecast Application, 2015 to 2029 Table 61: MEA Market Value (US$ Million) Analysis and Forecast Distribution Channel, 2015 to 2029 Table 62: MEA Market Volume (Units) Analysis and Forecast Distribution Channel, 2015 to 2029
Figure 01: Global Market Value (US$ Million) Forecast and Y-o-Y Growth, 2022 to 2029 Figure 02: Global Market: Absolute $ Opportunity, 2022 to 2029 Figure 03: Global Market Share (%) and BPS Analysis Product, 2022 to 2029 Figure 04: Global Compression Garments and Stocking Market Y-o-Y Growth (%) By Product, 2022 to 2029 Figure 05: Global Market Absolute $ Opportunity (US$ Million) By Compression Garments, 2022 to 2029 Figure 06: Global Market Absolute $ Opportunity (US$ Million) By Compression Stockings, 2022 to 2029 Figure 07: Global Market Attractiveness Analysis, by Product, 2022 to 2029 Figure 08: Global Market Share (%) and BPS Analysis Application, 2022 to 2029 Figure 09: Global Y-o-Y growth (%) By Application, 2022 to 2029 Figure 10: Global Market Absolute $ Opportunity (US$ Million) By Varicose Veins, 2022 to 2029 Figure 11: Global Market Absolute $ Opportunity (US$ Million) By Wound Care, 2022 to 2029 Figure 12: Global Market Absolute $ Opportunity (US$ Million) By Burns Cases, 2022 to 2029 Figure 13: Global Market Absolute $ Opportunity (US$ Million) By Oncology, 2022 to 2029 Figure 14: Global Market Absolute $ Opportunity (US$ Million) By Other Indications, 2022 to 2029 Figure 15: Global Market Attractiveness Analysis, by Application, 2022 to 2029 Figure 16: Global Market Share (%) and BPS Analysis Distribution Channel, 2022 to 2029 Figure 17: Global Y-o-Y growth (%) By Distribution Channel, 2022 to 2029 Figure 18: Global Market Absolute $ Opportunity (US$ Million) By Hospitals, 2022 to 2029 Figure 19: Global Market Absolute $ Opportunity (US$ Million) By Ambulatory Surgical Centres, 2022 to 2029 Figure 20: Global Market Absolute $ Opportunity (US$ Million) By Clinics, 2022 to 2029 Figure 21: Global Market Absolute $ Opportunity (US$ Million) By Online Sales, 2022 to 2029 Figure 22: Global Market Absolute $ Opportunity (US$ Million) By Other Healthcare Facilities, 2022 to 2029 Figure 23: Global Market Attractiveness Analysis, by Distribution Channel, 2022 to 2029 Figure 24: Global Market Share (%) and BPS Analysis Region, 2022 to 2029 Figure 25: Global Y-o-Y growth (%) By Region, 2022 to 2029 Figure 26: Global Market Absolute $ Opportunity (US$ Million) By North America, 2022 to 2029 Figure 27: Global Market Absolute $ Opportunity (US$ Million) By Western Europe, 2022 to 2029 Figure 28: Global Market Absolute $ Opportunity (US$ Million) By Eastern Europe, 2022 to 2029 Figure 29: Global Market Absolute $ Opportunity (US$ Million) By APEJ, 2022 to 2029 Figure 30: Global Market Absolute $ Opportunity (US$ Million) By Japan, 2022 to 2029 Figure 31: Global Market Absolute $ Opportunity (US$ Million) By Latin America, 2022 to 2029 Figure 32: Global Market Absolute $ Opportunity (US$ Million) By MEA, 2022 to 2029 Figure 33: Global Market Attractiveness Analysis, by Region, 2022 to 2029 Figure 34: North America Market Share Analysis (%) By Country, 2022 to 2029 Figure 35: North America Market Y-o-Y Growth (%) By Country, 2021 to 2029 Figure 36: The USA Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 37: Canada Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 38: North America Market Attractiveness Analysis Product, 2022 to 2029 Figure 39: North America Market Attractiveness Analysis Application, 2022 to 2029 Figure 40: North America Market Attractiveness Analysis Distribution Channel, 2022 to 2029 Figure 41: North America Market Attractiveness Analysis Country, 2022 to 2029 Figure 42: Western Europe Market Share Analysis (%) By Country, 2022 to 2029 Figure 43: Western Europe Market Y-o-Y Growth (%) By Country, 2021 to 2029 Figure 44: Germany Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 45: France Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 46: The UK Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 47: Italy Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 48: Spain Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 49: Rest of Western Europe Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 50: Western Europe Market Attractiveness Analysis Product, 2022 to 2029 Figure 51: Western Europe Market Attractiveness Analysis Application, 2022 to 2029 Figure 52: Western Europe Market Attractiveness Analysis Distribution Channel, 2022 to 2029 Figure 53: Western Europe Market Attractiveness Analysis Country, 2022 to 2029 Figure 54: Eastern Europe Market Share Analysis (%) By Country, 2022 to 2029 Figure 55: Eastern Europe Market Y-o-Y Growth (%) By Country, 2021 to 2029 Figure 56: Russia Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 57: Poland Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 58: Rest of Eastern Europe Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 59: Eastern Europe Market Attractiveness Analysis Product, 2022 to 2029 Figure 60: Eastern Europe Market Attractiveness Analysis Application, 2022 to 2029 Figure 61: Eastern Europe Market Attractiveness Analysis Distribution Channel, 2022 to 2029 Figure 62: Eastern Europe Market Attractiveness Analysis Country, 2022 to 2029 Figure 63: APEJ Market Share Analysis (%) By Country, 2022 to 2029 Figure 64: APEJ Market Y-o-Y Growth (%) By Country, 2021 to 2029 Figure 65: China Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 66: India Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 67: Australia & New Zealand Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 68: ASEAN Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 69: Rest of APEJ Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 70: APEJ Market Attractiveness Analysis Product, 2022 to 2029 Figure 71: APEJ Market Attractiveness Analysis Application, 2022 to 2029 Figure 72: APEJ Market Attractiveness Analysis Distribution Channel, 2022 to 2029 Figure 73: APEJ Market Attractiveness Analysis Country, 2022 to 2029 Figure 74: Japan Market Attractiveness Analysis Product, 2022 to 2029 Figure 75: Japan Market Attractiveness Analysis Application, 2022 to 2029 Figure 76: Japan Market Attractiveness Analysis Distribution Channel, 2022 to 2029 Figure 77: Latin America Market Share Analysis (%) By Country, 2022 to 2029 Figure 78: Latin America Market Y-o-Y Growth (%) By Country, 2021 to 2029 Figure 79: Brazil Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 80: Mexico Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 81: Rest of Latin America Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 82: Latin America Market Attractiveness Analysis Product, 2022 to 2029 Figure 83: Latin America Market Attractiveness Analysis Application, 2022 to 2029 Figure 84: Latin America Market Attractiveness Analysis Distribution Channel, 2022 to 2029 Figure 85: Latin America Market Attractiveness Analysis Country, 2022 to 2029 Figure 86: MEA Market Share Analysis (%) By Country, 2022 to 2029 Figure 87: MEA Market Y-o-Y Growth (%) By Country, 2021 to 2029 Figure 88: GCC Countries Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 89: South Africa Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 90: Rest of MEA Market Absolute $ Opportunity (US$ Million), 2021 to 2029 Figure 91: MEA Market Attractiveness Analysis Product, 2022 to 2029 Figure 92: MEA Market Attractiveness Analysis Application, 2022 to 2029 Figure 93: MEA Market Attractiveness Analysis Distribution Channel, 2022 to 2029 Figure 94: MEA Market Attractiveness Analysis Country, 2022 to 2029
Recommendations
Explore Healthcare Insights
View Reports